(800) 710-9770 Customer Service 8-5 Pacific
Anipryl (selegiline) 5 mg, 30 Tablets

Anipryl (selegiline) 5 mg, 30 Tablets

Retail: $102.99 Price: $74.27
Save: $28.72 (27.9%)

Item #: 1010421
Availability: Back Order
Email me when available
ETA Date: 1/14/2013

Anipryl 5 mg, 30 Tablets is the first FDA-approved monoamine oxidase inhibitor (MAOI) used to treat Canine Cognitive Dysfunction Syndrome. Anipryl (selegiline) also treats the symptoms associated with pituitary-dependent canine Cushing's Disease. Comes in easy-to-administer oral tablets with five different strengths.
  • Monoamine oxidase inhibitor (MAOI) for dogs
  • Helps manage the symptoms of canine Cushing's Disease
  • Used to treat dogs with behavioral changes brought on by aging and senility
  • Easy, once-daily oral dosing
  • Manufacturer information and usage PDF
Reviews
Product Reviews
Overall Customer Rating:
5.00
Customer Reviews: 1
Anipryl works
Rating:
Author:
Location:
Alameda, CA
Review Date:
7/17/2012

My dog was diagnosed with canine cognitive dysfunction, which is the same sort of disease as Alzheimer's in people. He was becoming more and more confused and cranky, he did not seem to recognize my daughter when she'd visit from out of town even though they grew up together, and he never wanted to play or do anything at all anymore. He is doing better now on this medication. I would not say 100% better, but he definitely seems more like the dog I've raised.
satisfaction Gauranteed

This information is for general reference only and should not be used for the diagnosis or treatment of any condition of your pet. Because is intended as a general reference, this information may not include all possible uses, precautions, directions, reactions (including allergic), drug interactions, or withdrawal times. Always consult your local veterinarian and have your pet examined for any advice concerning the diagnosis and treatment of your pet, including which products and doses are most appropriate. Any trademarks are the property of their respective owners.